May 3, 2018

This past week the Texas-Israel Chamber of Commerce conducted an interview with internationally renowned physician and scientist, Dr. Larry S. Schlesinger M.D., CEO and President of the Texas Biomedical Research Institute located in San Antonio, Texas. 

Dr. Schlesinger detailed the purpose of the Texas Biomedical Research Institute and stressed the importance of international collaboration on medical research. Schlesinger also outlined the institutes educational efforts towards developing the next generation of research scientists.

Q. What is t...

July 20, 2017

The world-renown Texas Biomedical Research Institute located in San Antonio, Texas, announced on June 19 that it plans to expand its “Biosafety Level 4 Facility” (BSL-4) with the interest of having greater capabilities to find cures to many kinds of infectious diseases.

Texas Biomed Research Institute’s President and CEO Dr. Larry Schlesinger explains this pivotal decision, “The Institute’s current biosafety level 4 laboratory, which is the highest safety level laboratory that allows for the study of the world’s deadliest pathogens, must expand if we are to meet the growin...

June 15, 2017

Houston’s Mayor, Sylvester Turner made a historic visit to Israel early this June in the hopes of creating more economic relations in the areas of energy and medical research and development (R&D) with the Jewish State. Houston economically dominates in these two areas as it is considered to be one of the greatest energy leaders in the world and houses the largest medical complex in the world (The Texas Medical Center), the largest Children’s hospital in the world (the Texas Children’s Hospital) and the largest cancer hospital in the world (MD Anderson Cancer Center).  Fu...

June 14, 2017

An Israeli biopharma company may have just created a possible cure for Type-1 Diabetes. Betalin Therapeutics, winner of the annual international MIXiii Biomed 2017 pharma startup competition, has made a micro-pancreas that performs the insulin secreting functions of a healthy non-diabetic pancreas. Type1-diabetes is an autoimmune disease that inhibits the pancreas from carrying out its proper functions in releasing insulin. Rather than transplanting cells that produce insulin to combat this form of diabetes, Betalin Therapeutics has chosen to embark on a more innovative a...

Please reload